FDA Inspection 813245 — Optimer Pharmaceuticals

Optimer Pharmaceuticals — FEI 3009793786

The FDA completed an inspection of Optimer Pharmaceuticals on Dec 21, 2012 in Jersey City, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 21, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Jersey City, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.